• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌腹水中的胱抑素和丝氨酸蛋白酶抑制剂B

Cystatins and stefins in ascites fluid from ovarian carcinoma.

作者信息

Lah T T, Kokalj-Kunovar M, Kastelic L, Babnik J, Stolfa A, Rainer S, Turk V

机构信息

Department of Biochemistry, Jozef Stefan Institute, Ljubljana, Slovenia.

出版信息

Cancer Lett. 1992 Jan 31;61(3):243-53. doi: 10.1016/0304-3835(92)90295-7.

DOI:10.1016/0304-3835(92)90295-7
PMID:1739949
Abstract

Cysteine proteinase inhibitors (CpI) of all three families were found in ascites fluid from patients with ovarian carcinoma. CPIs were isolated by affinity chromatography on carboxymethylated papain Sepharose, followed by gel filtration, anti-stefin-Sepharose and ion exchange chromatography. The highest apparent inhibition against cathepsin B (Cat B) was found in the low molecular mass (LMM) CPI fraction. Immunochemical analysis of this fraction revealed the presence of cystatin C and both stefins A and B while the high molecular mass (HMM) CPI fraction contained kininogens. We demonstrated that CPIs were not completely associated with cysteine proteinases (CPs): about 20% of HMM CPIs and 50% of LMM CPIs were free in native ascites fluid. Affinity chromatography on anti-Cat B-Sepharose revealed that the major LMM CPI, associated with Cat B in native ascites fluid, was the full length form of cystatin C, pI 9.3, and not its truncated form, pI 7.85. The latter was isolated and found to inhibit Cat B in vitro with apparent Ki 0.18 +/- 0.2 nM. Stefin A was isolated from alkaline activated ascites fluid in its two isoforms, pI 4.6 and 4.9. In native ascites, the pI 4.9 isoform was mostly associated with Cat B. Ki for Cat B was 3.55 +/- 1.7 nM, not significantly different from the Ki values measured for stefin A, isolated from other human tissues and biological fluids.

摘要

在卵巢癌患者的腹水液中发现了所有三个家族的半胱氨酸蛋白酶抑制剂(CpI)。通过羧甲基化木瓜蛋白酶琼脂糖凝胶亲和层析,随后进行凝胶过滤、抗丝抑蛋白琼脂糖凝胶和离子交换层析,从中分离出了CpI。在低分子量(LMM)CpI组分中发现了对组织蛋白酶B(Cat B)的最高表观抑制活性。对该组分进行免疫化学分析发现存在胱抑素C以及丝抑蛋白A和B,而高分子量(HMM)CpI组分中含有激肽原。我们证明CpI并非完全与半胱氨酸蛋白酶(CP)结合:在天然腹水液中,约20%的HMM CpI和50%的LMM CpI是游离的。抗组织蛋白酶B琼脂糖凝胶亲和层析显示,在天然腹水液中与组织蛋白酶B结合的主要LMM CpI是pI为9.3的全长胱抑素C,而非其截短形式pI 7.85。分离出截短形式并发现其在体外对组织蛋白酶B的抑制活性表观Ki为0.18±0.2 nM。从碱性激活的腹水液中分离出了两种同工型的丝抑蛋白A,其pI分别为4.6和4.9。在天然腹水中,pI为4.9的同工型主要与组织蛋白酶B结合。对组织蛋白酶B的Ki为3.55±1.7 nM,与从其他人体组织和生物体液中分离出的丝抑蛋白A所测得的Ki值无显著差异。

相似文献

1
Cystatins and stefins in ascites fluid from ovarian carcinoma.卵巢癌腹水中的胱抑素和丝氨酸蛋白酶抑制剂B
Cancer Lett. 1992 Jan 31;61(3):243-53. doi: 10.1016/0304-3835(92)90295-7.
2
Stefin B, the major low molecular weight inhibitor in ovarian carcinoma.
Cancer Lett. 1994 Jul 15;82(1):81-8. doi: 10.1016/0304-3835(94)90149-x.
3
Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.人肺癌细胞系中的组织蛋白酶B和半胱氨酸蛋白酶抑制剂
Clin Exp Metastasis. 1997 Jul;15(4):368-81. doi: 10.1023/a:1018494020001.
4
Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma.来自人肉瘤的低分子量半胱氨酸蛋白酶抑制剂的抑制特性
Biochim Biophys Acta. 1989 Oct 13;993(1):63-73. doi: 10.1016/0304-4165(89)90144-x.
5
Bovine stefin C, a new member of the stefin family.
J Biol Chem. 1993 Apr 5;268(10):7323-9.
6
Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids.
J Biol Chem. 1986 Aug 25;261(24):11282-9.
7
Isolation and characterization of bovine stefin B.牛类丝氨酸蛋白酶抑制剂B的分离与鉴定
Biol Chem Hoppe Seyler. 1992 Jul;373(7):441-6. doi: 10.1515/bchm3.1992.373.2.441.
8
Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases.丝氨酸蛋白酶抑制剂A、B和D与半胱氨酸蛋白酶相互作用的特异性差异。
FEBS Lett. 1996 Oct 21;395(2-3):113-8. doi: 10.1016/0014-5793(96)00984-2.
9
Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins.半胱氨酸蛋白酶的蛋白质抑制剂对其抑制作用的分子机制:胱抑素和丝抑素天然及重组变体的动力学研究
Biomed Biochim Acta. 1991;50(4-6):613-20.
10
Cystatins and cathepsins in breast carcinoma.乳腺癌中的胱抑素和组织蛋白酶
Biol Chem Hoppe Seyler. 1992 Jul;373(7):595-604. doi: 10.1515/bchm3.1992.373.2.595.

引用本文的文献

1
An Integrated Approach to Protein Discovery and Detection From Complex Biofluids.从复杂生物流体中进行蛋白质发现和检测的综合方法
Mol Cell Proteomics. 2023 Jul;22(7):100590. doi: 10.1016/j.mcpro.2023.100590. Epub 2023 Jun 9.
2
Cystatin-B Negatively Regulates the Malignant Characteristics of Oral Squamous Cell Carcinoma Possibly the Epithelium Proliferation/Differentiation Program.胱抑素B负向调节口腔鳞状细胞癌的恶性特征,可能是通过上皮增殖/分化程序实现的。
Front Oncol. 2021 Aug 24;11:707066. doi: 10.3389/fonc.2021.707066. eCollection 2021.
3
Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma.
所有蛋白酶基因的表达分析显示,组织蛋白酶K在胶质母细胞瘤中过表达。
PLoS One. 2014 Oct 30;9(10):e111819. doi: 10.1371/journal.pone.0111819. eCollection 2014.
4
Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway.半胱氨酸蛋白酶抑制剂 B 通过 TGF-β 信号通路促进人卵巢上皮性肿瘤的进展。
Int J Oncol. 2014 Apr;44(4):1099-106. doi: 10.3892/ijo.2014.2261. Epub 2014 Jan 21.
5
Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer.评估血清组织蛋白酶B前体、胱抑素B和胱抑素C作为卵巢癌潜在生物标志物的可能性。
Int J Circumpolar Health. 2013 Aug 5;72. doi: 10.3402/ijch.v72i0.21215. eCollection 2013.
6
Increased expression of cysteine cathepsins in ovarian tissue from chickens with ovarian cancer.在患有卵巢癌的鸡的卵巢组织中,半胱氨酸组织蛋白酶的表达增加。
Reprod Biol Endocrinol. 2010 Aug 21;8:100. doi: 10.1186/1477-7827-8-100.
7
Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors.卵巢肿瘤囊液中的组织蛋白酶 B、L 和半胱氨酸蛋白酶抑制剂 C。
J Cancer Res Clin Oncol. 2010 May;136(5):771-8. doi: 10.1007/s00432-009-0716-z. Epub 2009 Nov 14.
8
Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.人肺癌细胞系中的组织蛋白酶B和半胱氨酸蛋白酶抑制剂
Clin Exp Metastasis. 1997 Jul;15(4):368-81. doi: 10.1023/a:1018494020001.